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Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract. Though its exact etiology
is still unclear, it is proposed that an imbalance in the intestinal homeostasis leads to a disturbed interaction between
commensal microbiota and the mucosal immune system. Previous studies have shown that both innate and adaptive
immunity are involved in an overwhelming colon inflammation, and thus contribute to the pathogenesis of IBD. In innate
immunity, several pattern recognition receptors such as Toll-like receptors, NOD-like receptors or C-type lectin receptors
(CLRs) are involved in IBD pathogenesis. Myeloid CLRs are mainly expressed by antigen-presenting cells and bind to glycan
structures present on self or foreign antigens. The Macrophage-restricted C-type lectin (MCL) and the Dendritic cell
immunoreceptor (DCIR) are two poorly characterized members of the CLR family. In this study, we investigated the role of
MCL and DCIR in the pathogenesis of murine colitis. Both CLRs bound to intestinal microbiota to a different extent. They
modulated the production of pro-inflammatory cytokines by antigen-presenting cells upon stimulation with heat-killed
microbiota and impacted subsequent T cell responses. To analyze whether MCL and DCIR contribute to the pathogenesis of
IBD, the dextran sulfate sodium (DSS) murine colitis model was employed. MCL2/2 as well as DCIR2/2 mice exhibited only a
slightly increased severity of disease compared to wild-type mice indicating a limited role for MCL and DCIR in the
regulation of intestinal immunity.
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Introduction
Inflammatory bowel disease (IBD) is a chronic inflammatory
disorder of the gastrointestinal tract. In humans, there are two
major clinical forms: ulcerative colitis (UC) and Crohn’s disease
(CD) [1]. UC mainly affects the mucosa of the colon and rectum,
whereas inflammation in CD may occur in any part of the
gastrointestinal tract [2]. The incidence of IBD, particularly CD,
has dramatically increased in industrialized nations over the last
decades, however, the exact etiology of IBD still remains unclear
[3]. Several factors were reported to play a role in IBD
pathogenesis such as environmental factors, diet, genetic factors
and the immune system [1]. These factors can influence the
composition of commensal microorganisms in the intestine
followed by an imbalanced intestinal homeostasis which is a
major characteristic feature of IBD [4].
Pattern recognition receptors (PRRs) expressed by antigen
presenting cells (APCs), especially dendritic cells (DCs), function as
receptors for endogenous as well as pathogenic antigens [5]. In a
healthy gut, DCs sample intestinal antigens with the help of PRRs,
internalize them, migrate to local lymphoid tissue and subse-
quently present the processed antigens to T cells [6]. Thus, PRRs
are essential for DCs to maintain intestinal immune homeostasis
[6]. Based on their physiological function, several PRRs such as
NOD2, NLRP3 and several Toll-like receptors (TLRs) were
demonstrated to influence the pathogenesis of IBD [7–9]. Several
TLR-deficient mice or mice lacking the adaptor protein MyD88
exhibited an increased susceptibility to experimental colitis
induced by oral administration of dextran sodium sulfate (DSS)
[8,10]. The DSS model is commonly used to investigate the
contribution of innate immunity to the pathogenesis of IBD
[11,12]. An increased susceptibility to DSS-induced colitis was also
reported for mice deficient for the cytosolic NOD-like receptors
(NLRs) NOD1 and NOD2 [9].
C-type lectin receptors (CLRs) recognize various classes of
pathogens [13–15]. They are mainly expressed by antigen-
presenting cells such as monocytes, macrophages, and DCs and
recognize carbohydrate moieties on pathogens as well as on self-
antigens [16,17]. Many CLRs such as DC-SIGN, SIGNR3,
Dectin-2, MGL or Langerin are internalized after ligand binding
followed by processing of the antigen and subsequent MHC class
II presentation or cross-presentation to T cells [16]. Previous
studies indicate that CLRs play a crucial role in the regulation of
intestinal immune homeostasis and colon inflammation [18]. A
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polymorphism in the human Dectin-1 gene (CLEC7A) is
associated with a severe form of UC [19]. Consistently, mice
deficient in Dectin-1 exhibited increased susceptibility to DSS-
induced colitis due to an altered response to commensal intestinal
fungi [19]. The Macrophage galactose-type lectin-1 (MGL1) plays
a regulatory role in murine colitis as it contributes to IL-
10 secretion by lamina propria macrophages upon interaction
with invading commensal bacteria [20]. Mice deficient for the
murine DC-SIGN homologue SIGNR1 exhibited a reduced
susceptibility to experimental colitis since SIGNR1 acts synergis-
tically with TLR4 in the initiation of an inflammatory response
upon LPS binding by TLR4 [21]. Recently, it was demonstrated
that the murine CLR SIGNR3 plays a protective role in
chemically induced colitis in mice [22]. A number of studies
focused on the role of the Mannose-binding lectin (MBL) in
intestinal inflammation. Mice deficient for MBL exhibited an
increased susceptibility to DSS-induced colitis and MBL in
humans was reported to ameliorate the excessive inflammation
during IBD [23,24].
Two poorly characterized CLRs are the Macrophage-restricted
C-type lectin (MCL) and the Dendritic cell immunoreceptor
(DCIR). MCL is a type II transmembrane glycoprotein with a
single extracellular C-type lectin domain and is expressed by
myeloid cells, mainly resting macrophages [25,26]. The human
MCL was found to be rapidly endocytosed upon receptor cross-
linking [26]. Recently, it has been reported that (rat) MCL forms a
heterodimer with the macrophage inducible C-type lectin (Mincle)
[27]. MCL recognizes the mycobacterial glycolipid trehalose-6,6-
dimycolate (TDM) which is a natural ligand of Mincle [28,29] but
no further ligands of MCL were identified up to now. A recent
study indicated that MCL acts as an activating receptor that
mediates phagocytosis, respiratory burst, and inflammatory
cytokine production [30]. In addition to its role in mycobacterial
infection, MCL is also involved in the immune response against
Klebsiella pneumoniae infection [28,31].
DCIR is expressed by DCs, B cells, monocytes, macrophages,
and neutrophils [32] and was found to be internalized upon
binding of a DCIR-specific antibody [33]. Furthermore, DCIR
targeting allowed for antigen processing and presentation for
efficient CD4+ as well as CD8+ T cell priming [34,35]. DCIR is
the only classical CLR with an intracellular immunoreceptor
tyrosine-based inhibitory motif (ITIM) [36]. Upon activation, it
recruits SHP-1 and SHP-2 phosphatases which subsequently
promote the inhibition of ITAM signaling, particularly of Syk-
coupled CLRs [16]. Based on its function, DCIR is down-
regulated upon activation of DCs and plays an inhibitory role in
the response to pathogens [32,36].
In the present study, we investigated the role of MCL and
DCIR in murine experimental colitis. Binding studies using CLR-
hFc fusion proteins showed that MCL and to a low extent DCIR
bound to commensal intestinal microbes. Furthermore, stimula-
tion of MCL- and DCIR-deficient APCs with heat-killed
commensal microbiota revealed a modulatory role of both CLRs
in the production of pro-inflammatory cytokines. To analyze the
role of MCL and DCIR in intestinal immunity in vivo, the murine
DSS colitis model was employed. Local MCL mRNA levels in the
colon were increased during experimental colitis. However,
MCL2/2 as well as DCIR2/2 mice exhibited only a slightly
increased disease severity based on either clinical symptoms or
histopathology compared to wild-type mice indicating a limited
role for MCL and DCIR in the regulation of intestinal immunity.
Materials and Methods
Generation of bone-marrow derived macrophages and
dendritic cells
For cell stimulation studies, bone marrow-derived macrophages
(BMMs) or bone marrow-derived dendritic cells (BMDCs) were
generated from C57BL/6 J wild-type, DCIR2/2 (031932-UCD,
DCIR KO/Mmcd), and MCL2/2 (031935-UCD, MCL KO/
Mmcd) mice. Bone marrow cells were prepared from murine hind
legs by flushing the uncovered and opened femurs and tibiae with
medium. Red blood cells were lysed by addition of a buffer
containing 144 mM ammonium chloride and 10 mM Tris-HCl
pH 7.2 for 5 min. Subsequently, cells were separated with a cell
strainer and cultivated in full IMDMmedium (10% FCS, 200 mM
L-glutamine, 10.000 U/mL penicillin, 10 mg/mL streptomycin)
supplemented with 5% horse serum and 30% L929 cell
supernatant for generation of BMMs or with 10% culture
supernatant of GM-CSF transfected X-63 cells for generation of
BMDCs [37]. The culture medium was replaced every two or
three days and the cells were used for stimulation studies between
day 7 and day 9.
Binding studies with CLR-hFc fusion proteins
Analysis of commensal microbiota recognition by distinct CLRs
was performed by incubating respective hFc fusion proteins with
murine faecal samples. The extracellular parts of MCL, DCIR,
and MGL1 were expressed as hFc fusion proteins as described
previously [38–40]. Faecal samples were isolated from colon of
female C57BL/6 J mice, filtered through a 40 mm cell strainer
(BD Biosciences, Heidelberg, Germany), adjusted to an OD600 of
0.6 with sterile PBS and inactivated at 65uC for 2 h. Commensal
microbes present in the samples were labeled with SYTO 61
fluorescent dye (Life Technologies, Darmstadt, Germany) at
2.5 mM in PBS for 30 min. CLR-hFc fusion proteins were added
to the microbiota samples at 1 mg/mL in lectin buffer (50 mM
HEPES, 5 mM CaCl2, 5 mM MgCl2, pH 7.4) supplemented with
0.5% (w/v) BSA at 4uC for 1 h. As a negative control, the hFc
fragment alone was used. Bound fusion proteins were detected
using PE-conjugated anti-hFc antibody (Dianova, Hamburg,
Germany), diluted 1:100 (v/v), at 4uC for 30 min. Gram-positive
Table 1. Scoring for assessment of the disease activity index.
Score Blood in faeces Stool consistency Weight loss (%)
0 No blood detected Normal 0
1 1–3
2 Blood detected Loose stool 3–6
3 6–9
4 Gross blood detected Diarrhea .9
doi:10.1371/journal.pone.0103281.t001
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intestinal bacteria were detected by co-staining with the lectin
wheat germ agglutinin (WGA)-AF 647 (Life Technologies) at
1 mg/mL that recognizes N-acetylglucosamine (GlcNAc) moieties
[41]. Samples were washed three times after each staining step and
subsequently analyzed by flow cytometry using a FACS Canto II
flow cytometer (BD Pharmingen, Heidelberg, Germany). The
FlowJo (Tree Star Inc., Ashland, OR) software was used for data
analysis.
Stimulation studies with commensal intestinal microbes
For cell stimulation with intestinal microbiota, murine faeces
were prepared as described above. For direct stimulation of APCs,
16105 BMMs or BMDCs per well were seeded in a flat-bottom
plate in full IMDM medium and were stimulated with various
dilutions of faecal samples for 18 h. As positive control, cells were
incubated with 1000 ng/mL LPS (Sigma Aldrich, St. Louis, MO)
or plate-coated zymosan (Imgenex, San Diego, CA). The next day,
cytokine concentrations in the culture supernatants were measured
by ELISA. Commercial ELISA kits were used for the determina-
tion of IL-6, IL-10 (Peprotech, Rocky Hill, NY) and TNF-a (R&D
Systems, Minneapolis, MN) and the detection was performed
according to manufacturer’s instructions.
To analyze the impact of MCL and DCIR on T cell
stimulation, OT-II T cells were purified from spleen by MACS
using the Pan T Cell Isolation Kit II (Miltenyi Biotec, Bergisch
Gladbach, Germany) according to the manufacturer’s instructions.
36104 BMMs or 1.56104 BMDCs were pulsed with 30 mg/mL
ovalbumin (OVA, Hyglos, Bernried am Starnberger See, Ger-
many) in the presence of different dilutions of faecal samples and
co-cultivated with 16105 OT-II T cells in a round-bottom 96 well
plate. 10 mg/mL of OVA323–339 was used as positive control. After
72 h, T cell activation was analyzed by determination of IL-2 and
IFN-c in the cell culture supernatant using ELISA development
kits (Peprotech).
Ethics statement
Animal experiments were performed in strict accordance with
the German regulations of the Society for Laboratory Animal
Science and the European Health Law of the Federation of
Laboratory Animal Science Associations. The protocol, including
the definition of strict humane endpoints, was approved by the
Landesamt fu¨r Gesundheit und Soziales Berlin (Permit No.
G0052/10). All efforts were made to minimize suffering.
Animals
C57BL/6-Tg (TcraTcrb) 425Cbn/J mice ( =OT-II mice), CLR
gene-deficient mouse lines and the respective C57BL/6 J control
mice were housed and bred in the animal facility of the Federal
Institute for Risk Assessment (BfR) in a temperature- and
humidity-controlled room under specific pathogen-free conditions.
Food and water were provided ad libitum. DCIR2/2 (031932-
UCD, DCIR KO/Mmcd) mice and MCL2/2 (031935-UCD,
MCL KO/Mmcd) mice were obtained from the National
Institutes of Health-sponsored Mutant Mouse Regional Resource
Center (MMRRC) National System. Genotyping of the MCL or
DCIR gene in wild-type and MCL- or DCIR-deficient mice was
performed using a protocol provided by the Consortium for
Functional Glycomics (Figure S1).
DSS-induced colitis
All DCIR2/2, MCL2/2 and C57BL/6 J mice used in the
experiment were female, between 8 and 10 weeks old and had a
body weight of around 20 g at the beginning of the study. Five or
six mice of different strains were randomly put together in the
same cage at least two weeks before the experiment to ensure
similar conditions for mice of different groups. For colitis
induction, 3% DSS (w/v) (reagent grade, 35–50 g/mol; MP
Biomedicals, Illkirch, France) was added to the drinking water for
seven consecutive days. The body weight was recorded daily. On
day seven, mice were sacrificed and a disease activity index (DAI)
was assessed for each mouse in a blinded manner. The scoring
system with scores of 0–4 was based on stool consistency, blood
presence in stool and weight loss as described in previous colitis
studies [21,22], modified from [42] (Table 1). Blood in faeces was
detected with Greegor’s modified Guaiak test (Haemoccult,
Beckman Coulter, Galway, Ireland) according to the manufactur-
er’s instructions. The colon of each mouse was prepared and its
length was measured since colon contraction is a characteristic
feature of colitis [43]. Subsequently, the colon was either fixed in
4% buffered formalin for histological analysis or flushed with PBS,
snap-frozen in liquid nitrogen and stored at –80uC for later
cytokine determination or mRNA expression analysis.
mRNA expression analysis by semi-quantitative RT-PCR
For the detection of MCL and DCIR mRNA levels in the colon
of untreated and DSS-treated C57BL/6 J mice, total RNA was
isolated using the Tri Reagent solution (Life technologies). 2 mL of
the solution was added to each frozen colon and samples were
incubated at RT for 5 min. Colon tissues were subsequently
homogenized using an IKA T10 homogenizer (IKA-Werke
GmbH, Staufen, Germany). Cells were further lysed by passing
the sample through a 20-gauge needle using a 1 mL syringe. After
removal of cell debris by centrifugation at 12000 g and 4uC for
10 min, RNA isolation was performed according to the manufac-
turer’s instructions. 1 mg of purified RNA was then applied to
DNase I digestion (NEB, Frankfurt am Main, Germany) followed
by cDNA synthesis using AMV reverse transcriptase (NEB). At this
step, a negative control was included for each sample where no
reverse transcriptase was added. 1 mL of cDNA per sample was
used for DNA amplification by PCR using specific primers for
MCL (fw 59-TCATTACTTTTTACGCTGGA-39, rev 59-
ACAAATCCTTCTCACCTCAAAG-39), DCIR (fw 59-
GCTACTTCTCCTGCTGCTGG-39, rev 59-TCCAGTCTTC-
Table 2. Scoring for the histological evaluation of intestinal lesions.
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CAACGGTAAA-39), b-actin (fw 59-GTCGTACCACAGG-
CATTGTGATGG-39, rev 59-GCAATGCCTGGGTA-
CATGGTGG-39). As a positive control, cDNA from BMMs (for
MCL) or from BMDCs (for DCIR) was used. For visualization of
DNA bands, DNA-Dye NonTox (AppliChem, Darmstadt, Ger-
many) was added to the PCR products and samples were loaded
on a 1.5% agarose gel.
Figure 1. MCL and DCIR recognize commensal intestinal microbiota and modulate APC and T cell cytokine production. Binding of
MCL- and DCIR-hFc fusion proteins to stained gut microbes was analyzed by flow cytometry. (A) Representative dot plots of one binding experiment
with MCL- and DCIR-hFc, with hFc as negative control, and with MGL1-hFc as positive control. Gating and frequencies indicate binding events of CLR-
hFc fusion proteins to commensal microbiota. For analysis, it was first gated on Syto 61 positive events ( = stained microbiota) followed by gating on
PE positive events ( = CLR-Fc fusion proteins). Data are representative of three independent experiments (triplicates each). (B) MCL2/2 and wild-type
BMMs or (C) DCIR2/2 and wild-type BMDCs were stimulated with various concentrations of heat-killed gut microbiota, LPS or coated zymosan for
18 h (triplicates each). TNF-a levels in the culture supernatants were determined by ELISA. TNF-a production was significantly increased for MCL2/2
BMMs and DCIR2/2 BMDCs compared to wild-type APCs. Data are representative of three independent experiments. For analysis of T cell activation,
purified OT-II transgenic T cells were co-cultivated with BMMs or BMDCs in the presence of heat-killed gut microbiota and 30 mg/mL OVA for 72 h.
(D) IL-2 and (E) IFN-c levels were determined in the culture supernatants of stimulated MCL2/2 and wild-type BMMs. Similarly, (F) IL-2 and (G) IFN-c
levels were analyzed in the culture supernatants of stimulated DCIR2/2 and wild-type BMDCs. Data are representative of three independent
experiments (triplicates each) and are expressed as mean + SEM. The p-values were determined with unpaired Student’s t-test (*p,0.05, **p,0.01).
Significance is indicated by asterisks (*), ns = no significance.
doi:10.1371/journal.pone.0103281.g001
Figure 2. Clinical symptoms of DSS-induced colitis in MCL2/2 and DCIR2/2 mice. Colitis was induced in wild-type, MCL2/2 and DCIR2/2
mice by adding 3% DSS into the drinking water for seven consecutive days. (A) MCL and DCIR mRNA levels were analyzed by semi-quantitative RT-
PCR in colon of untreated and DSS-treated wild-type mice (6 mice per group). As a control, RNA was also isolated from colon of untreated MCL2/2 or
DCIR2/2 mice. b-actin expression levels were determined in all samples to ensure the same quantity and quality of cDNA. MCL mRNA expression in
colon of DSS-treated mice was increased compared to the colon of untreated mice while DCIR mRNA levels did not differ between untreated and
DSS-treated mice. Disease severity was determined by the daily body weight loss for MCL2/2 mice (n = 11) (B), and for DCIR2/2 mice (n = 18) (E), the
colon length for MCL2/2 mice (C), and for DCIR2/2 mice (F), and a disease activity index (DAI) based on blood occurrence, stool consistency and
body weight loss for MCL2/2 mice (n = 11 for wild-type and n=10 for MCL2/2 mice) (D), and for DCIR2/2 mice (n = 13 for wild-type and n= 12 for
DCIR2/2 mice) (G). Data shown are the combined results of two (MCL) or three (DCIR) independent experiments. On day six, one MCL2/2 mouse had
to be euthanized due to the defined humane endpoints. MCL2/2 mice displayed an increased body weight loss compared to wild-type mice, with a
significant difference on day 5 and 6. The colon length and DAI did not vary between MCL2/2 and wild-type mice. No significant difference in body
weight, colon length, and DAI between DCIR2/2 and wild-type mice was observed. Data are expressed as mean + SEM. The p-values were determined
with Mann-Whitney’s U test (*p,0.05). Significance is indicated by asterisks (*), ns = no significance.
doi:10.1371/journal.pone.0103281.g002
MCL and DCIR in Colitis
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Histological analysis of colon sections
Histological analyses were performed as previously described
[22]. Briefly, each mouse colon was fixed with 4% buffered
formalin and embedded in paraffin. Sections of 4 mm thickness
were prepared and stained with hematoxylin and eosin (H&E).
Subsequently, they were examined in a blinded manner by an
experienced histologist. Each colon was divided into three
segments of identical length and each part was graded according
to the degree of leukocyte infiltration and mucosal damage
(Table 2).
Determination of colonic cytokines
For cytokine determination, thawed colons were homogenized
using an IKA T10 homogenizer after addition of a modified
Greenberger lysis buffer containing 300 mM NaCl, 15 mM Tris,
2 mM MgCl2, 0.5% Triton X-100, protease-inhibitor X, and
protease-inhibitor HP (Serva Electrophoresis, Heidelberg, Ger-
many). Protein concentration was determined with the Pierce
BCA Protein Assay Kit (Thermo Scientific, Rockford, IL) with
BSA as a standard. The concentrations of the cytokines IL-6, IL-
1b, TNF-a, IL-10, and IL-12p70 in colon homogenates were
determined by cytometric bead array (BD Biosciences) following
manufacturer’s instructions. Samples were measured using a
Figure 3. Histological analysis of colon sections from wild-type and MCL2/2mice. Paraffin sections of the colon from untreated or 3% DSS-
treated wild-type and MCL2/2 mice were prepared at day seven and were stained with hematoxylin and eosin (H&E) for histological evaluation in a
blinded manner. Each colon was divided into three segments of identical length (oral, middle, rectal) which were separately analyzed. (A)
Representative images of paraffin-embedded sections of the rectal part of the colon are shown (40x magnification). The degree of leukocyte
infiltration (B) and mucosal erosion/ulceration (C) was graded from none (score 0) to mild (score 1), moderate (score 3), or severe (score 4). Data are
expressed as mean + SEM (n= 8 for wild-type and n=5 for MCL2/2 mice). The p-values were determined using Mann-Whitney’s U test. Significance is
indicated by asterisks (*), ns = no significance.
doi:10.1371/journal.pone.0103281.g003
MCL and DCIR in Colitis
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FACS Canto II flow cytometer (BD Biosciences) and data were
analyzed with the FCAP Array software (BD Bioscience).
Statistical analysis
Statistical analyses were performed with Mann-Whitney’s U test
for all in vivo data. In vitro data were analyzed with unpaired
Student’s t test. Data analysis was performed using the Prism
software (GraphPad Software, La Jolla, CA). A p-value of p,0.05
was considered statistically significant.
Results
Binding of MCL and DCIR to commensal microbiota
The interaction of certain CLRs with commensal intestinal
microbes has been shown in previous studies [19,22]. To analyze
whether MCL and DCIR interact with murine intestinal
commensals, MCL- and DCIR-hFc fusion proteins were gener-
ated as previously reported [38] and used for binding studies. The
CLR-hFc fusion proteins were incubated with heat-killed intestinal
microbes and binding was analyzed by flow cytometry using a
fluorescently labeled anti-hFc antibody. MGL1-hFc was used as
positive control since binding of this CLR to commensal
microbiota was shown in a previous study [20]. As expected,
hFc alone did not bind to intestinal microbiota whereas MGL1-
Figure 4. Histological analysis of colon sections from wild-type and DCIR2/2 mice. Paraffin sections of the colon from untreated or 3%
DSS-treated wild-type and DCIR2/2 mice were prepared at day seven and were stained with hematoxylin and eosin (H&E) for histological evaluation
in a blinded manner. (A) Representative images of paraffin-embedded sections of the rectal part of the colon are shown (40x magnification). Arrows
indicate a severe ulcer in the colon from DCIR2/2 mice. Each colon was divided into three segments of identical length (oral, middle, rectal) which
were separately analyzed. The degree of leukocyte infiltration (B) and mucosal erosion/ulceration (C) was graded from none (score 0) to mild (score
1), moderate (score 3), or severe (score 4). The scores for both, cell infiltration as well as mucosal ulceration in the rectal part of the colon from DCIR2/
2 mice were significantly increased compared to wild-type mice. Data are expressed as mean + SEM (n= 5). The p-values were determined using
Mann-Whitney’s U test (*p,0.05, **p,0.01). Significance is indicated by asterisks (*), ns = no significance.
doi:10.1371/journal.pone.0103281.g004
MCL and DCIR in Colitis
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hFc exhibited substantial binding to commensal microbiota
(Figure 1A). MCL-Fc also recognized a considerable portion of
intestinal microbes (Figure 1A). DCIR-Fc only bound to a
marginal portion of commensal microorganisms, still DCIR-Fc
binding was significantly increased compared to the binding of hFc
alone (*p=0.031, Figure 1A, and data not shown). Co-staining
experiments with the lectin WGA that binds to GlcNAc moieties
indicated that a minor portion of WGA+ microbiota was
recognized by MCL-Fc (data not shown). For instance, GlcNAc
moieties are present in the cell wall of gram-positive bacteria
species [41]. The nature of the MCL ligand remains to be
determined in future studies.
Microbiota recognition by MCL and DCIR modulates TNF-
a production by APCs
The binding studies with the MCL- and DCIR-hFc fusion
proteins and murine faeces indicate a direct interaction between
MCL and, to a low extent, DCIR with intestinal commensal
microbes. To analyze the impact of microbiota stimulation on
APC effector functions, BMMs or BMDCs from wild-type and
MCL2/2 or DCIR2/2 mice were incubated with heat-killed
microbiota of a murine faeces suspension. MCL is predominantly
expressed by macrophages [25,26] whereas DCIR is mainly
expressed by immature DCs [32,36]. Consequently, BMMs from
MCL2/2 or C57BL/6 control mice and BMDCs from DCIR2/2
or C57BL/6 control mice were stimulated with heat-killed
microbiota. The stimulation experiments revealed a significantly
higher TNF-a production by MCL2/2 BMMs upon microbiota
stimulation compared to wild-type BMMs (Figure 1B) whereas
stimulation with the positive controls zymosan or LPS led to
similar TNF-a levels. When BMDCs from DCIR2/2 or wild-type
mice were stimulated with heat-killed faeces suspensions, a
significantly higher TNF-a production by DCIR2/2 BMDCs
was observed (Figure 1C), particularly at higher faeces concen-
trations. In tendency, the same effect as for TNF-a was observed
for IL-6 levels (data not shown). However, IL-10 production did
not differ between wild-type and CLR-deficient APCs (Figure S2).
These findings indicate that the recognition of microbiota by MCL
and DCIR correlates with a modulated pro-inflammatory cytokine
production by APCs.
Impact of microbiota recognition by MCL and DCIR on T
cell activation
To analyze whether the differential microbiota recognition by
wild-type and CLR-deficient APCs impacted subsequent T cell
activation, APCs from MCL2/2, DCIR2/2 and wild-type mice
were pulsed with the model antigen OVA in the presence of
various concentrations of heat-killed intestinal microbiota. Then,
OT-II T cells whose TCR is specific for the OVA323–339 peptide
presented by the MHC-class-II molecule I-Ab were added [44].
Cytokine analysis revealed an increased production of IL-2 and
IFN-c when OT-II T cells were co-cultivated with MCL2/2
BMMs in the presence of low faeces concentrations (Figure 1D,
E). Whereas the IL-2 production by OT-II T cells co-cultured with
DCIR2/2 BMDCs in the presence of OVA/microbiota was
significantly increased (Figure 1F), no marked difference was
observed for IFN-c levels (Figure 1G). These findings indicate that
MCL and DCIR not only affect APC functions, but may also
modulate subsequent T cell responses.
Figure 5. Local cytokine concentrations in the colon of wild-type, MCL2/2, and DCIR2/2 mice. Colons from untreated wild-type mice or
from wild-type and MCL2/2 mice (n = 6) (A), or wild-type and DCIR2/2 mice (n = 7 for wild-type and n= 8 for DCIR2/2 mice) (B) treated with 3% DSS
for seven consecutive days were homogenized and used for cytokine determination by cytometric bead array. Data are expressed as mean + SEM.
Significance is indicated by asterisks (*), ns = no significance.
doi:10.1371/journal.pone.0103281.g005
MCL and DCIR in Colitis
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Limited role for MCL and DCIR in DSS colitis
To determine the role of the CLRs MCL and DCIR in
intestinal immunity, the murine DSS colitis model was employed.
It is commonly used to mechanistically investigate the contribution
of innate immunity to colitis pathogenesis since adaptive immunity
plays a minor role in this model [12]. DSS is toxic to gut epithelial
cells and leads to disruption of the mucosal barrier [11], thus it
promotes a direct interaction between commensal microbes and
APCs in the gut. MCL and DCIR mRNA expression analysis by
semi-quantitative RT-PCR revealed increased MCL mRNA levels
in the colon of DSS-treated wild-type mice compared to untreated
mice (Figure 2A). In contrast, the local DCIR mRNA levels were
not altered during DSS colitis (Figure 2A). During experimental
colitis, MCL2/2 mice exhibited a significantly increased weight
loss compared to wild-type mice on day 5 and 6 (Figure 2B)
indicating a protective role for MCL. Clinical symptoms or weight
loss were not present in untreated MCL2/2, DCIR2/2 or wild-
type mice (data not shown). On day six, one MCL2/2 mouse had
to be taken out of the experiment due to a too severe weight loss
compared to untreated control mice. Since acute colitis leads to
colon shortening, the length of each colon was determined on day
seven. Indeed, colon length was significantly reduced in all mice
treated with DSS compared to untreated mice (Figure 2C).
Additionally, a disease activity index (DAI) was assessed in a
blinded manner based on stool consistency, the presence of occult
blood and weight loss (Table 1). However, no difference in the
DAI as well as in the colon length between MCL2/2 and wild-
type mice was detected (Figure 2C, D) suggesting a limited role for
MCL in murine colitis. No difference in body weight loss between
DCIR2/2 mice and wild-type mice was observed (Figure 2E).
Furthermore, no significant difference in colon length (Figure 2F)
or DAI (Figure 2G) occurred between DCIR2/2 and wild-type
mice during DSS colitis. These findings suggest that DCIR might
be dispensable for intestinal immunity in this model of experi-
mental colitis.
Histological analysis of colon sections
For further analysis of the grade of disease, a representative
number of colon sections from untreated mice and DSS-treated
mice were used for histological evaluation. Scores for different
grades of leukocyte infiltration and mucosal damage (Table 2)
were applied in a blinded manner. During acute colitis, mucosal
inflammation causes colonic lesions, ulcers, and bleeding. Thus,
granulocytes infiltrating into the lamina propria and submucosa
are characteristic features of IBD. Mucosal damage was assessed
by analyzing structural changes of the mucosa such as an irregular
surface or distortion of the crypt architecture which also includes
fibrosis or crypt abscesses. For histological analysis, colon sections
were stained with hematoxylin and eosin (Figure 3A). Scores for
cell infiltration as well as mucosal ulceration were the same for
MCL2/2 and wild-type mice (Figure 3B, C). Thus, MCL does not
impact leukocyte infiltration into the colon and mucosal damage
during experimental colitis. Histological analysis of colon samples
from DCIR2/2 mice revealed more severe ulcers in the rectal part
of the colon of DCIR2/– mice compared to wild-type mice
(Figure 4A). This finding was manifested by a significantly higher
score for leukocyte infiltration as well as for mucosal damage in the
rectal part of the colon of DCIR-deficient mice compared to wild-
type mice (Figure 4B, C). In tendency, the same difference was
observed for mucosal ulceration in the oral part of the colon
(Figure 4C). These findings indicate that DCIR moderately
impacts mucosal damage and leukocyte infiltration during acute
colitis though the clinical colitis symptoms were similar in DCIR2/
2 and wild-type mice (ref. Figure 2).
Local cytokine concentrations in the colon
Local cytokine concentrations in the colon were measured
during the acute phase of DSS colitis. However, no difference in
the levels of the pro-inflammatory cytokines TNF-a, IL-6 and IL-
1b was observed between MCL2/2 or DCIR2/2 and wild-type
mice, respectively (Figure 5). Moreover, the concentration of the
immune regulatory cytokine IL-10 was similar in DSS-treated
wild-type, MCL-, and DCIR-deficient mice (data not shown).
Thus, local cytokine levels did not differ between MCL2/2 and
DCIR2/2 mice compared to wild-type mice. In summary, the
DSS colitis studies suggest a minor role for MCL and DCIR in
regulating colon inflammation during experimental colitis.
Discussion
In the present study, we analyzed the role of the CLRs MCL
and DCIR in murine experimental colitis. As members of the PRR
family, CLRs play a crucial role in the recognition of pathogens
[45]. They are mainly expressed by APCs and generally bind to
carbohydrates present on self or foreign antigens [16,17]. During
IBD, the mucosal barrier in the intestine becomes disrupted
followed by an aberrant interaction between commensal intestinal
microbes and epithelial cells as well as local immune cells [43].
DCIR has already been shown to recognize self and foreign
antigens [46], and to play a crucial role in maintaining the
homeostasis of the immune system during the pathogenesis of
autoimmune diseases [47]. It has also recently been reported to be
involved in the pathogenesis of experimental cerebral malaria
[48]. MCL has been demonstrated to bind to the mycobacterial
glycolipid TDM [28,29] and to play a role in the immune response
against mycobacteria and Klebsiella pneumoniae infection [28,31].
Based on these functions of MCL and DCIR in immune
homeostasis and microbial recognition, we investigated the role
of both CLRs in murine colitis. Indeed, binding studies using
CLR-hFc fusion proteins revealed a direct interaction of MCL
with a considerable portion of commensal intestinal microbiota.
Stimulation of APCs with intestinal microbes and APC/T cell co-
cultivation assays indicated a regulatory role of MCL and DCIR in
TNF-a production by APCs and in subsequent T cell responses.
To analyze the role of MCL and DCIR in intestinal immunity
in vivo, the phenotype of MCL- and DCIR-deficient mice was
characterized in the DSS colitis model which is a common model
to investigate the contribution of innate immunity to IBD
pathogenesis [11,12]. The increased MCL mRNA level in the
colon of DSS-treated mice suggests a role of MCL in intestinal
immunity. The difference in expression might be due to infiltration
of MCL-expressing cells into the colon during experimental colitis
or due to MCL up-regulation on APC subsets. However, it was
reported that MCL is constitutively expressed in myeloid cells and
no up-regulation was observed upon in vitro stimulation with
TDM [28] rendering an infiltration of MCL+ cells into the colon
more likely. Furthermore, MCL2/2 mice exhibited an increased
weight loss compared to wild-type mice, but other clinical
symptoms were similar for MCL2/2 and wild-type mice. It has
been proposed that MCL is an activating receptor which is
coupled to the spleen tyrosine kinase (Syk) signaling pathway [30].
A recent study demonstrated that MCL delivers activating signals
through an ITAM-containing FcRc chain [28]. Several activating
CLRs have already been described to play a regulatory role in
IBD. For instance, Dectin-1 and SIGNR3 modulate immune
pathology in chemically induced colitis [19,22]. In addition to
CLRs, NLRs play a crucial role in colitis, as mice deficient for
NOD2 exhibited more severe clinical symptoms than wild-type
mice during the process of colitis [49]. NOD2 binds to the
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microbial ligand muramyl dipeptide and activates the NF-kB
signaling pathway [50]. However, NOD2 was also reported to
promote the secretion of the anti-inflammatory cytokine IL-10 as
well as proliferation of regulatory T cells during murine colitis
[51].
The characterization of the DCIR2/2 mice in the DSS colitis
model indicated a minor role for DCIR in murine colitis. DCIR
mRNA levels were not altered during experimental colitis,
however, DCIR was described to be down-regulated during
activation of DCs [36] which might have been compensated
during experimental colitis by cell infiltration in the colon.
Although no difference was observed in body weight loss and
colon length of mice, higher histological scores for leukocyte
infiltration and mucosal damage in the rectal part of the colon
were detected for DCIR-deficient mice. DCIR has previously been
shown to bind to mannose- or fucose-based glycan structures [52].
It also binds to self-antigens present on keratinocytes and to
foreign antigens such as the envelope glycoprotein E2 of Hepatitis
C virus (HCV) [46,53]. Recently, DCIR was shown to bind to
sialylated intravenous immunoglobulin and to play a role in
induction of regulatory T cells during allergic airway inflammation
in mice [54]. Hence, DCIR might also recognize glycan structures
present on gut antigens although we observed only slight binding
of a DCIR-hFc fusion protein to heat-killed intestinal microbes.
However, this slight binding might also be due to the glycosylation
of the CRD in the DCIR-hFc fusion protein since it was recently
shown that DCIR exhibits higher ligand affinity in a deglycosy-
lated form [46,52]. DCIR is the only classical CLR with an
intracellular immunoreceptor tyrosine-based inhibitory motif
(ITIM) and plays an inhibitory role in response to pathogens
[32,36]. Furthermore, DCIR was reported as a negative regulator
of DC expansion [47]. The modulatory effect of DCIR was
markedly seen in vitro upon stimulation of BMDCs with heat-
killed intestinal microbes. In vivo, its immune modulatory role was
only observed with regard to leukocyte cell infiltration and
mucosal damage in the colon. However, it has to be taken into
account that other CLRs might also be involved in the regulation
of intestinal inflammation. Thus, compensatory effects might
explain the limited role of DCIR in colitis observed in the DSS
model.
In conclusion, MCL and DCIR modulate TNF-a production
upon stimulation of APCs with heat-killed microbiota but play a
limited role in intestinal immunity during the pathogenesis of
DSS-induced colitis. Further studies are needed to investigate the
impact of multiple CLRs in intestinal immunity and potential
compensatory mechanisms.
Supporting Information
Figure S1 Genotyping of DCIR2/2 andMCL2/2mice by
PCR. (A) Genotyping of the DCIR gene in wild-type and
DCIR2/2 mice was performed with the following primers
(sequences provided from the Consortium for Functional Glyco-
mics): DR 177 (59-GCCACATGCTCAGCCTTCAG-39), DR
483 (59CACTGTGGGACGTTACTGTC-39), DR 484 (59-
GGACCATTTTCTTCTGCCTAGA-39). The wild-type band
has a size of 748 bp, while the DCIR knockout band is 457 bp.
Shown is the representative analysis of genomic DNA of wild-type
(+/+), heterozygous (+/2) and DCIR deficient (2/2) mice. (B)
Genotyping of the MCL gene in wild-type and MCL2/2 mice was
performed with the following primers (sequences provided from
the Consortium for Functional Glycomics): MC.612 (59-GTA-
TAATGTATGCTATACGAAGTTATCTCGAG-39), MC.613
(59-CTGAAAAAACTTATTGCTCATAATTTACACAGTAT-
39), MC.614 (59-GGAGGCTTTGGGAGCACATG-39). The
wild-type band has a size of 550 bp, while the MCL knockout
band is 360 bp.
(TIF)
Figure S2 IL-10 production by APCs stimulated with
heat-killed commensal intestinal microbiota. (A) MCL2/
2 and wild-type BMMs or (B) DCIR2/2 and wild-type BMDCs
were stimulated with various concentrations of heat-killed gut
microbiota or with LPS as positive control for 18 h (triplicates
each). IL-10 levels in the cell culture supernatants were determined
by ELISA. Data are representative of three independent
experiments and are expressed as mean + SEM. The p-values
were determined with unpaired Student’s t-test (*p,0.05).
Significance is indicated by asterisks (*), ns = no significance.
(TIF)
Checklist S1 ARRIVE Guidelines Checklist. The informa-
tion on the ARRIVE (Animal Research: Reporting In Vivo
Experiments) guidelines are included in the manuscript as
indicated in the checklist.
(PDF)
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